News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News FDA Approves Two Additional Indications for Rivaroxaban in Children L.A. McKeown December 21, 2021
News Daily News PASCAL Pinpoints Patients With Strokes Causally Related to PFO Yael L. Maxwell December 20, 2021
News Conference News AHA 2021 Racial/Ethnic Disparities in AF Care Persist Despite Dual VA, Medicare Coverage Todd Neale November 19, 2021
News Conference News AHA 2021 Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown Yael L. Maxwell November 14, 2021
News Conference News AHA 2021 GIRAF: Cognitive Outcomes Similar With Dabigatran, Warfarin in Older AF Patients Todd Neale November 14, 2021
News Conference News TCT 2021 Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets Caitlin E. Cox November 06, 2021
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Conference News TCT 2021 PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term Todd Neale November 05, 2021
News Daily News Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR Yael L. Maxwell November 03, 2021
News Daily News Predictors of AF May Help Guide Care After Stroke of Unknown Cause Caitlin E. Cox October 26, 2021
News Conference News EACTS 2021 More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients Michael O'Riordan October 18, 2021
News Conference News TCT 2021 LAA Closure Feasible in Patients With Thrombus: Registry Michael O'Riordan October 13, 2021
News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021